Iron chelators as antimalarial agents: In vitro activity of dicatecholate against Plasmodium falciparum

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 2, 2002, Pages 177-187

  Pradines, B ^a,b   Rolain, J M ^b,c   Ramiandrasoa, F ^d   Fusai, T ^a,b   Mosnier, J ^a,b   Rogier, C ^a,b   Daries, W ^a,b   Baret, E ^a,b   Kunesch, G ^d   Le Bras, J ^e   Parzy, D ^a,b  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b Inst Federatif de la Recherche 48   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITÉ PARIS SUD   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ASCORBIC ACID; ATOVAQUONE; BIS(2,3 DIHYDROXYBENZOYL) SPERMIDINE HYDROBROMIDE DERIVATIVE; CATECHOL DERIVATIVE; CHLOROQUINE; CYCLOGUANIL; DEFEROXAMINE MESYLATE; DIHYDROARTEMISININ; DOXYCYCLINE; FERRIC ION; FERRITIN; FERROUS ION; FR 160; FREE RADICAL; IRON CHELATING AGENT; NITROGEN; PRIMAQUINE; PYRIMETHAMINE; PYRONARIDINE; UNCLASSIFIED DRUG; CATECHOL; CHOLIC ACID DERIVATIVE;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG STRUCTURE; ERYTHROCYTE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; LIPID SOLUBILITY; LIPOPHILICITY; MALARIA; MAMMAL CELL; NONHUMAN; PLASMODIUM FALCIPARUM; SCHIZONT; STRAIN DIFFERENCE; TROPHOZOITE; VERO CELL; ANIMAL; CERCOPITHECUS; CHEMISTRY; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING;

ANIMALS; ANTIMALARIALS; CATECHOLS; CERCOPITHECUS AETHIOPS; CHOLATES; ERYTHROCYTES; IRON CHELATING AGENTS; PLASMODIUM FALCIPARUM; VERO CELLS;

EID: 0036668105     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf104     Document Type: Article

References (57)

1. Impact of chloroquine resistance on malaria mortality
2. The development and spread of drug-resistant malaria
3. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya
4. Failure of anti-malarial prophylaxis with mefloquine in Africa
5. Type RI resistance to halofantrine in West Africa
6. Paludisme à Plasmodium falciparum: Résistance de type RI à la quinine en Afrique de l'Est
7. New targets for antimalarial drug discovery
8. Iron chelation as a chemotherapeutic strategy for falciparum malaria
9. The treatment of malaria with iron chelators
10. The role of iron in protozoan and fungal infectious diseases
11. Iron chelators as antimalarials: The biochemical basis of selective cytotoxicity
12. Mode of action of iron (III) chelators as antimalarials. II. Evidence for differential on parasite iron-dependent nucleic acid synthesis
13. Mode of action of iron(III) chelators as antimalarials. I. Membrane permeation properties and cytotoxic activity
14. Parasite uptake of desferrioxamine: A prerequisite for antimalarial activity
15. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators
16. Iron chelators: Mode of action as antimalarials
17. In vitro activities of novel catecholate siderophore against Plasmodium falciparum
18. Synchronization of Plasmodium falciparum erythrocytic stages in culture
19. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of antineoplastic drugs
20. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90)
21. A micro-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs
22. A method for testing for synergy with any number of agents
23. Reversed siderophores act as antimalarial agents
24. Differential cytotoxicity of iron chelators on malaria infected cells versus mammalian cells
25. Iron chelation therapy for malaria: A review
26. Antimalarial properties of orally active iron chelators
27. The combined effect of iron chelators and classical antimalarials on the in vitro growth of Plasmodium falciparum
28. Activity of chloroquine and desferrioxamine in vitro against newly isolated Plasmodium falciparum and their antagonism in combination
29. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by an fluorescent derivative of Desferal
30. Antimalarial effect of HEBD and other phenolic and catecholic iron chelators
31. Mode of action of iron(III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives
32. Hydrophobic iron chelators as new antimalarial drugs
33. Aminothiol multidentate chelators as antimalarials
34. Plasmodium falciparum and Plasmodium yoeli effect of the iron chelation prodrug dexrazoxane on in vitro culture
35. Stage-dependent effect of desferrioxamine on growth of Plasmodium falciparum in vitro
36. Specific ultrastructural effects of desferrioxamine on Plasmodium falciparum in vitro
37. Antibiotics for prophylaxis of Plasmodium falciparum infections: In vitro activity of doxycycline against Senegalese isolates
38. Arteether, a new antimalarial drug: Synthesis and antimalarial properties
39. Iron-dependent free radical generation from the antimalarial agent artemisinin (Qinghaosu)
40. Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin
41. Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy
42. Artemisinin (qinghaosu): The role of intracellular hemin in its mechanism of antimalarial action
43. Artemisinin enhanced heme-catalysed oxidation of lipid membranes
44. Enhancement of hemin-induced membrane damage by artemisinin
45. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
46. Malarial haemozoin/β-hematin supports haem polymerization in the absence of protein
47. A micro-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs
48. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification system in malarial parasite
49. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerisation in Plasmodium falciparum in vitro
50. Deferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine
51. The antimalarial action of Desferal involves a direct access route to erythrocytic parasites (P. falciparum)
52. Plasmodium falciparum: Inhibition of in vitro growth by desferrioxamine
53. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase
54. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents
55. Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives
56. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron
57. In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum